» Articles » PMID: 12351693

Identification of a Novel Human Organic Anion Transporting Polypeptide As a High Affinity Thyroxine Transporter

Overview
Journal Mol Endocrinol
Date 2002 Sep 28
PMID 12351693
Citations 99
Authors
Affiliations
Soon will be listed here.
Abstract

Transport of various amphipathic organic compounds is mediated by organic anion transporting polypeptides (OATPs in humans, Oatps in rodents), which belong to the solute carrier family 21A (SLC21A/Slc21a). Several of these transporters exhibit a broad and overlapping substrate specificity and are expressed in a variety of different tissues. We have isolated and functionally characterized OATP-F (SLC21A14), a novel member of the OATP family. The cDNA (3059 bp) contains an open reading frame of 2136 bp encoding a protein of 712 amino acids. Its gene containing 15 exons is located on chromosome 12p12. OATP-F exhibits 47-48% amino acid identity with OATP-A, OATP-C, and OATP8, the genes of which are clustered on chromosome 12p12. OATP-F is predominantly expressed in multiple brain regions and Leydig cells of the testis. OATP-F mediates high affinity transport of T(4) and reverse T(3) with apparent K(m) values of approximately 90 nM and 128 nM, respectively. Substrates less well transported by OATP-F include T(3), bromosulfophthalein, estrone-3-sulfate, and estradiol-17beta-glucuronide. Furthermore, OATP-F-mediated T(4) uptake could be cis-inhibited by L-T(4) and D-T(4), but not by 3,5-diiodothyronine, indicating that T(4) transport is not stereospecific, but that 3',5'-iodination is important for efficient transport by OATP-F. Thus, in contrast to most other family members, OATP-F has a more selective substrate preference and may play an important role in the disposition of thyroid hormones in brain and testis.

Citing Articles

Spatially dependent tissue distribution of thyroid hormones by plasma thyroid hormone binding proteins.

Bagga A, Johnson B, Zhang Q Pflugers Arch. 2025; 477(3):453-478.

PMID: 39751918 DOI: 10.1007/s00424-024-03060-6.


Testicular immunity.

Li S, Kumar S, Gu X, DeFalco T Mol Aspects Med. 2024; 100:101323.

PMID: 39591799 PMC: 11624985. DOI: 10.1016/j.mam.2024.101323.


Toward a treatment for thyroid hormone transporter MCT8 deficiency - achievements and challenges.

Markova B, Mayerl S, Heuer H Eur Thyroid J. 2024; 13(6).

PMID: 39485732 PMC: 11623285. DOI: 10.1530/ETJ-24-0286.


Brain Abnormalities in Young Single- and Double-Heterozygote Mice for Both Nkx2-1- and Pax8-Null Mutations.

Giacco A, Iervolino S, Cioffi F, Peluso T, Mercurio G, Roberto L Mol Neurobiol. 2024; 62(4):4023-4041.

PMID: 39375286 PMC: 11880048. DOI: 10.1007/s12035-024-04524-7.


Two novel in vitro assays to screen chemicals for their capacity to inhibit thyroid hormone transmembrane transporter proteins OATP1C1 and OAT4.

Wagenaars F, Cenijn P, Chen Z, Meima M, Scholze M, Hamers T Arch Toxicol. 2024; 98(9):3019-3034.

PMID: 38761188 PMC: 11324666. DOI: 10.1007/s00204-024-03787-2.